参考文献/References:
[1] Guillevin L, Durand-Gasselin B, Cevallos R, et al.Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients[J].Arthritis Rheum, 1999,42(3):421-430.
[2] Jennette JC, Falk RJ, Andrassy K, et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference[J].Arthritis Rheum,1994,37(2):187-192.
[3] 中华医学会风湿病学分会.显微镜下多血管炎诊断及治疗指南[J].中华风湿病学杂志,2011,15(4):259-261.
[4] Koldingsnes W, Nossent HC.Epidemiology of ANCA associated vasculitis[J].Norsk Epidemiologi,2008,18(1):37-48.
[5] Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al.Stable incidence of primary systemic vasculitides over five years:results from the German vasculitis register[J].Arthritis Rheum,2005,53(1):93-99.
[6] Watts RA, Lane SE, Bentham G, et al.Epidemiology of systemic vasculitis:a ten-year study in the United Kingdom[J].Arthritis Rheum,2000,43(43):414-419.
[7] Mahr A, Guillevin L, Poissonnet M, et al.Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000:a capture-recapture estimate[J].Arthritis Rheum,2004,51(1):92-99.
[8] Mohammad AJ, Jacobsson LT, Mahr AD, et al.Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg Strauss syndrome within a defined population in southern Sweden[J].Rheumatology, 2007,46(8):1329-1337.
[9] Frankel SK, Sullivan EJ, Brown KK.Vasculitis:Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis[J].Crit Care Clin,2002,18(4):855-879.
[10] Bourgarit A, le Toumelin P, Pagnoux C, et al.Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome:a retrospective analysis of causes and factors predictive of mortality based on 595 patients[J].Medicine(Baltimore),2005,84(5):323-330.
[11] Morgan MD, Turnbull J, Selamet U, et al.Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides:a matched-pair cohort study[J].Arthritis Rheum, 2009,60(11):3493-3500.
[12] Suppiah R, Judge A, Batra R, et al.A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis[J].Arthritis Care Res(Hoboken),2011,63(4):588-596.
[13] Lhote F, Cohen P, Guillevin L.Polyarteritis nodosa, microscopic polyangiitis and Churg-strauss syndrome[J].Lupus,1998,7(6):238-258.
[14] Schrader ML, Hochman JS, Bulkley BH.The heart in polyarteritis nodosa:a clinicopathologic study[J].Am Heart J,1985,109(6):1353-1359.
[15] Mavrogeni S, Papadopoulos G, Karanasios E, et al.Microscopic polyangiitis and Kawasaki disease without overt clinical cardiovascular manifestations and with abnormal cardiovascular magnetic resonance findings[J].Int J Cardiol,2010,141(1):e17-e19.
[16] Pagnoux C, Guillevin L.Cardiac involvement in small and medium-sized vessel vasculitides[J].Lupus,2005,14(9):718-722.
[17] Hughes LB, Bridges SL.Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations[J].Curr Rheumatol Rep,2002,3(1):75-82.
[18] Kaur P, Palya A, Hussain H, et al.Microscopic polyangiitis presenting as early cardiac tamponade[J].J Clin Rheumatol,2010,16(2):86-87.
[19] Allenbach Y, Seror R, Pagnoux C, et al.High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa:a systematic retrospective study on 1 130 patients[J].Ann Rheum Dis,2009,68(4):564-567.
[20] Hagen EC, Daha MR, Hermans J, et al.Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis.EC/BCR Project for ANCA Assay Standardization[J].Kidney Int, 1998,53(3):743-753.
[21] Ribi C,Cohen P,Pagnoux C,et al.Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors:a prospective randomized study of one hundred twenty-four patients[J].Arthritis Rheum, 2010,62(4):1186-1197.
[22] Hogan SL, Nachman PH, Wilkman AS, et al.Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis[J].J Am Soc Nephrol,1996,7(1):23-32.
相似文献/References:
[1]吴亚希,杨丽霞.Toll样受体4与心血管疾病的研究进展[J].心血管病学进展,2016,(1):58.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.015]
WU Yaxi,YANG Lixia.Research Progress of Relationship Between Toll-like Receptor 4 and
Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(2):58.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.015]
[2]汪汉,综述.几种少见的风湿性疾病的心血管表现[J].心血管病学进展,2016,(3):305.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.024]
WANG Han.Cardiovascular Manifestations in Rare Rheumatic Diseases[J].Advances in Cardiovascular Diseases,2016,(2):305.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.024]
[3]李子进,综述,李景东,等.锚蛋白B在心血管系统中作用的研究进展[J].心血管病学进展,2016,(4):341.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.004]
LI Zijin,LI Jingdong.Research Progress of Ankyrin-B in Cardiovascular System[J].Advances in Cardiovascular Diseases,2016,(2):341.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.004]
[4]万永伦,综述,高倩萍,等.红细胞分布宽度与心血管疾病之间的病理生理联系[J].心血管病学进展,2016,(4):387.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.016]
WAN Yonglun,GAO Qianping.Pathophysiological Connection Between Red Blood Distribution
Width and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2016,(2):387.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.016]
[5]孟雅洁,综述,付真彦,等.芳香化酶基因与心血管相关疾病的研究进展[J].心血管病学进展,2016,(4):405.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.020]
MENG Yajie,FU Zhenyan.Progress in Research of the Relationship Between CYP19A1
Gene and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(2):405.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.020]
[6]冉丹,佘强.载脂蛋白C-Ⅲ在心血管疾病中的研究进展[J].心血管病学进展,2015,(5):613.[doi:10.3969/j.issn.1004-3934.2015.05.023]
RAN Dan,SHE Qiang.Progress of Apolipoprotein C-Ⅲ in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2015,(2):613.[doi:10.3969/j.issn.1004-3934.2015.05.023]
[7]隆雪原,罗素新.睡眠与心血管疾病相互关系的研究进展[J].心血管病学进展,2015,(6):735.[doi:10.3969/j.issn.1004-3934.2015.06.020]
LONG Xueyuan,LUO Suxin.Research Progress of the Relationship Between Sleep and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(2):735.[doi:10.3969/j.issn.1004-3934.2015.06.020]
[8]李涛 杨思姝 钱永军.纳米技术在心血管疾病中的最新应用[J].心血管病学进展,2019,(5):708.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.012]
LI Tao,YANG Sishu,QIAN Yongjun.Nanotechnology in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(2):708.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.012]
[9]潘乐 汪翔 龚惠.单细胞测序在心血管系统中的应用[J].心血管病学进展,2020,(12):1227.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.001]
PAN Le,WANG Xiang,GONG Hui.Application of single cell sequencing in cardiovascular system[J].Advances in Cardiovascular Diseases,2020,(2):1227.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.001]
[10]于洋杰 谢坤 高秀芳 施海明 李勇.非高密度脂蛋白胆固醇可以替代低密度脂蛋白胆固醇吗？[J].心血管病学进展,2021,(1):12.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
YU Yangjie,XIE Kun,GAO Xiufang,et al.Can LDL-C be Replaced by non-HDL-C[J].Advances in Cardiovascular Diseases,2021,(2):12.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]